Collectively, our data demonstrate that SPHK1‐packaged EVs mediates extracellular modulation of S1P signaling, promoting the growth of ovarian tumors via immune suppression (Figure 6H). The gene discussed is MBTPS1; the disease is ovarian neoplasm.